Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
eWeek1d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
GlobalData on MSN3d
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
BioPharma Dive3d
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
pharmaphorum3d
Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...